IRIS
FAGONE, PAOLO FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.523
EU - Europa 3.296
AS - Asia 2.865
SA - Sud America 582
AF - Africa 549
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 13.825
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.338
SG - Singapore 1.502
RU - Federazione Russa 1.138
IT - Italia 927
CN - Cina 869
BR - Brasile 527
IE - Irlanda 431
CI - Costa d'Avorio 303
UA - Ucraina 279
SN - Senegal 155
DE - Germania 148
VN - Vietnam 148
CA - Canada 142
KR - Corea 104
GB - Regno Unito 81
SE - Svezia 63
IN - India 48
NL - Olanda 44
FI - Finlandia 35
JP - Giappone 33
MX - Messico 33
PL - Polonia 26
AR - Argentina 25
BD - Bangladesh 24
FR - Francia 22
ZA - Sudafrica 22
IR - Iran 21
BE - Belgio 17
BJ - Benin 16
IQ - Iraq 16
KE - Kenya 16
ES - Italia 15
EC - Ecuador 14
HK - Hong Kong 14
CH - Svizzera 13
UZ - Uzbekistan 13
TR - Turchia 12
LT - Lituania 11
NG - Nigeria 10
ID - Indonesia 9
AE - Emirati Arabi Uniti 8
AT - Austria 7
MA - Marocco 7
PK - Pakistan 7
BG - Bulgaria 6
GR - Grecia 6
EU - Europa 5
GE - Georgia 5
LB - Libano 5
TN - Tunisia 5
VE - Venezuela 5
AU - Australia 4
EG - Egitto 4
MK - Macedonia 4
RO - Romania 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
MY - Malesia 3
AL - Albania 2
AO - Angola 2
CL - Cile 2
CO - Colombia 2
HU - Ungheria 2
KG - Kirghizistan 2
PE - Perù 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 13.825
Salva come PNG Salva come JPEG
Città #
Dallas 1.935
Singapore 864
Santa Clara 800
Moscow 539
Chandler 464
Dublin 430
Jacksonville 305
Abidjan 303
Chicago 290
Ashburn 255
Hefei 225
Catania 208
Houston 208
Boardman 202
Beijing 158
Dakar 155
Cambridge 117
Lawrence 117
Andover 112
Los Angeles 105
Seoul 103
Nanjing 88
Civitanova Marche 83
Toronto 80
New York 74
Des Moines 65
San Mateo 51
São Paulo 48
Wilmington 48
Grafing 45
Rome 44
Palermo 42
Amsterdam 37
Dong Ket 36
Ho Chi Minh City 34
Buffalo 33
Saint Petersburg 32
The Dalles 32
Columbus 31
Hanoi 31
Tokyo 31
Nanchang 29
Lappeenranta 27
Ottawa 27
Munich 26
Jiaxing 24
Boston 23
Hebei 23
Nizza di Sicilia 23
Council Bluffs 22
Denver 22
Brooklyn 21
London 21
San Jose 21
Vercelli 21
Orem 20
Rio de Janeiro 20
Messina 19
Washington 19
Bremen 18
Johannesburg 18
Montreal 18
Sant'Antonio Abate 18
Tianjin 18
Warsaw 18
Brussels 17
Stockholm 17
Acireale 16
Augusta 16
Cotonou 16
Phoenix 16
San Francisco 16
Atlanta 15
Changsha 15
Milan 15
Hong Kong 13
Shenyang 13
Ardabil 12
Leawood 12
Poplar 11
Abuja 10
Bronte 10
Chennai 10
Dearborn 10
Guangzhou 10
Mexico City 10
Belo Horizonte 9
Campinas 9
Curitiba 9
Licata 9
Padova 9
Baghdad 8
Dhaka 8
Mascalucia 8
Mumbai 8
Paris 8
Ragusa 8
Seattle 8
Vancouver 8
Chiaramonte Gulfi 7
Totale 9.772
Salva come PNG Salva come JPEG
Nome #
The role of macrophages in neuroinflammatory and neurodegenerative pathways of alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets 266
Advances in targeting signal transduction pathways. 224
Differential modulation and prognostic values of immune-escape genes in uveal melanoma 224
KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms 201
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 193
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. 189
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 176
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. 169
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 160
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets 159
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy 156
Characterization of the pathophysiological role of CD47 in uveal melanoma 156
Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? 156
CD4+T-cell gene expression of healthy donors, HIV-1 and elite controllers: Immunological chaos 148
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 146
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences 143
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs 141
Exploratory analysis of iPSCS-derived neuronal cells as predictors of diagnosis and treatment of Alzheimer disease 141
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-Releasing Molecule CORM-A1, in a murine model of Autoimmune Hepatitis 139
Emerging therapeutic targets for the treatment of hepatic fibrosis 136
17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease 136
Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. 135
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 135
Impaired expression of tetraspanin 32 (TSPAN32) in memory T cells of patients with multiple sclerosis 135
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma 133
Identification of novel targets for the diagnosis and treatment of liver fibrosis. 133
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis 132
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 131
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets 128
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis 127
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 126
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis 126
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF 122
Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis. 121
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer 121
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L 114
mTOR as a multifunctional therapeutic target in HIV infection 114
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 113
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 113
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells 113
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2 111
). NO-hybridized protease inhibitors as a new class of anticancer compounds. Saquinavir-NO as prototypical example?. 111
Cathepsin A levels in CD4+ T cells from HIV-positive patients 110
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 110
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 109
Comprehensive Analysis of TSPAN32 Regulatory Networks and Their Role in Immune Cell Biology 108
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 107
Modulation of heat shock proteins during macrophage differentiation. 107
Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis 107
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus 106
Effects of GIT-27NO, a NO-donating compound, on hepatic ischemia/reperfusion injury 104
Immunoexpression and localization of heme-oxygenase-1 and MIF in lung exposed to asbestos-like fibers: an in vivo study 99
Meta-analysis of transcriptomic data of dorsolateral prefrontal cortex and of peripheral blood mononuclear cells identifies altered pathways in Schizophrenia 99
Comprehensive analysis of rna-seq gene expression profiling of brain transcriptomes reveals novel genes, regulators, and pathways in autism spectrum disorder 99
In silico and in vivo analysis of IL37 in multiple sclerosis reveals its probable homeostatic role on the clinical activity, disability, and treatment with fingolimod 97
Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-β secretion by antigen-specific CD8 T cells 96
The dichotomic role of macrophage migration inhibitory factor in neurodegeneration 96
Effects of treatment with the hypomethylating agent 5-aza-2’-deoxycytidine in murine type ii collagen-induced arthritis 96
CAN THE IMMUNOMODULATORY POTENTIAL OF CARBON-OXIDERELEASING MOLECULES BE TRANSLATED INTO THE CLINICAL SETTING AS A NOVEL THERAPEUTIC OPTION FOR THE TREATMENT OF AUTOIMMUNE DISEASES? 93
Evaluation of Toll-like Receptor 4 (TLR4) Involvement in Human Atrial Fibrillation: A Computational Study 91
Overexpression of macrophage migration inhibitory factor and its homologue d-dopachrome tautomerase as negative prognostic factor in neuroblastoma 91
Hypomethylating agent 5-aza-2 ′-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models 90
Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis 88
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis 88
Vitamin D3 inhibits TNFα-induced latent HIV reactivation in J-LAT cells. 87
Therapeutic potential of carbon monoxide in multiple sclerosis 87
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 86
Characterization of a small molecule modulator of inflammatory cytokine production 84
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway 84
Sensitization of cancer stem cells based on inhibiting key signal transduction pathways 83
Therapeutic potential of nitric oxide-modified drugs in colon cancer cells 83
No-Modified Saquinavir is Equally Efficient Against Doxorubicin Sensitive and Resistant Non-Small Cell Lung Carcinoma Cells/MODIFIKOVANA KOVANA FORMA SAKVINAVIRA EFIKASNO SU PRIMI RA RAST ĆELIJA NESITNOĆELIJSKOG KARCINOMA PLUĆA RAZLIČITE OSETUIVOSTI NA DOKSORUBICIN 83
Immune modifying capacity of new melanoma therapeutics with the potency to increase efficacy of Adoptive T-cell Therapy – potential synergism of combinations 82
Overexpression of macrophage migration inhibitory factor and functionally‑related genes, D‑DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma 82
Effects of combined admistration of imatinib and sorafenib in a murine model of liver fibrosis 81
Gene Co-Expression Network Modular Analysis Reveals Altered Immune Mechanisms in HIV-HAND 80
Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression 80
The immunobiology of apotransferrin in type 1 diabetes 79
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor 79
Role of NGAL (Lcn2) in prostate cancer invasion 79
Modulation of tetraspanin 32 (TSPAN32) expression in T cell-mediated immune responses and in multiple sclerosis 79
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy 78
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients 78
Effects of Synthetic Anti-Inflammatory Sterol in CB3V-Induced Myocarditis: A Morphological Study on Heart Muscle Tissue 78
The cytokine network in the pathogenesis of major depressive disorder. Close to translation? 78
Identification of Common Pathogenetic Processes between Schizophrenia and Diabetes Mellitus by Systems Biology Analysis 78
New melanoma therapeutics to improve adoptive T cell therapy - potential synergism of combinations 77
Naturally occurring compounds in differentiation based therapy of cancer. 77
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1 77
Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders 77
The role of macrophage migration inhibitory factor in Alzheimer′s disease: Conventionally pathogenetic or unconventionally protective? 77
Transcriptomic analysis reveals involvement of the macrophage migration inhibitory factor gene network in duchenne muscular dystrophy 77
Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review) 77
A DNA vaccine against Chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates 77
Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL 76
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 75
The effect of omega-3 fatty acids on capsular tissue around the breast implants 75
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy 74
NO-hybridized protease inhibitors as novel drugs for the treatment of cancer and autoimmune diseases 73
Expression of DNA methylation genes in secondary progressive multiple sclerosis 73
Totale 11.194
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021371 0 0 0 0 0 16 66 5 84 5 144 51
2021/2022865 76 119 4 19 143 21 126 33 65 3 20 236
2022/20231.587 124 82 29 127 145 246 18 347 350 27 48 44
2023/2024793 47 105 46 60 37 243 8 44 4 23 90 86
2024/20253.288 40 502 200 149 774 326 152 111 243 283 295 213
2025/20265.825 497 1.335 1.222 484 985 1.302 0 0 0 0 0 0
Totale 14.067